• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国结节病患者的临床特征和结局。

Clinical characteristics and outcomes of Korean patients with sarcoidosis.

机构信息

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

University of Ulsan College of Medicine, Seoul, South Korea.

出版信息

Sci Rep. 2021 Dec 8;11(1):23700. doi: 10.1038/s41598-021-03175-1.

DOI:10.1038/s41598-021-03175-1
PMID:34880400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8654965/
Abstract

Sarcoidosis is a systemic granulomatous disorder of unknown cause involving multiple organs. Its clinical presentation and prognosis vary among races. We identified the clinical characteristics and outcomes of Korean patients with sarcoidosis. Clinical data of 367 Korean patients with biopsy-proven sarcoidosis diagnosed in 2001-2017 were retrospectively analyzed. Treatment responses included improvement, stability, or progression based on changes in pulmonary sarcoidosis on chest images. The mean age was 47.4 years, and 67.3% of patients were women. The median follow-up period was 80 months. The highest prevalence was observed in individuals aged 50-59 years (30-39 years in men, 50-59 years in women), and the number of diagnoses showed an increasing trend. Lung involvement was the most common (93.5%), followed by the skin, eyes, and extrathoracic lymph nodes. Among patients with lung involvement and a follow-up period of ≥ 3 months, 66.8%, 31.0%, and 2.2% showed improvement, stability, and progression, respectively. Eleven patients (2.9%) died, and the 5-year survival rate was 99%. The number of diagnosed cases showed an increasing trend, and the mean age at diagnosis was increased compared with that in previous reports. Organ involvement was similar to that of Westerners, although the prognosis appeared better.

摘要

结节病是一种原因不明的系统性肉芽肿性疾病,涉及多个器官。其临床表现和预后在不同种族之间存在差异。我们确定了韩国结节病患者的临床特征和结局。回顾性分析了 2001 年至 2017 年间经活检证实的 367 例韩国结节病患者的临床资料。治疗反应根据胸部图像上的肺结节病变化分为改善、稳定或进展。患者的平均年龄为 47.4 岁,67.3%为女性。中位随访时间为 80 个月。发病率最高的年龄段为 50-59 岁(男性为 30-39 岁,女性为 50-59 岁),且诊断数量呈上升趋势。肺部受累最常见(93.5%),其次是皮肤、眼睛和胸外淋巴结。在有肺部受累且随访时间≥3 个月的患者中,分别有 66.8%、31.0%和 2.2%的患者病情改善、稳定和进展。11 例(2.9%)患者死亡,5 年生存率为 99%。诊断病例数量呈上升趋势,与以往报告相比,诊断时的平均年龄有所增加。器官受累与西方人相似,尽管预后似乎更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/d4a90cbe7325/41598_2021_3175_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/7b836b53085d/41598_2021_3175_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/bf8e1cc87e3b/41598_2021_3175_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/b7b80aa46775/41598_2021_3175_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/d4a90cbe7325/41598_2021_3175_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/7b836b53085d/41598_2021_3175_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/bf8e1cc87e3b/41598_2021_3175_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/b7b80aa46775/41598_2021_3175_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fa/8654965/d4a90cbe7325/41598_2021_3175_Fig4_HTML.jpg

相似文献

1
Clinical characteristics and outcomes of Korean patients with sarcoidosis.韩国结节病患者的临床特征和结局。
Sci Rep. 2021 Dec 8;11(1):23700. doi: 10.1038/s41598-021-03175-1.
2
Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: A nationwide population-based study.2003-2015 年韩国结节病的患病率、发病率和死亡率:一项基于全国人口的研究。
Respir Med. 2018 Nov;144S:S28-S34. doi: 10.1016/j.rmed.2018.03.028. Epub 2018 Apr 3.
3
Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts.结节病的临床特征和器官系统受累:明尼苏达大学队列与其他队列的比较。
BMC Pulm Med. 2020 Jun 1;20(1):155. doi: 10.1186/s12890-020-01191-x.
4
Sarcoidosis in southern Taiwan.台湾南部的结节病
J Formos Med Assoc. 2002 Nov;101(11):803-5.
5
The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases.结节病的共病和复杂性负担:相关慢性疾病的影响。
Lung. 2018 Apr;196(2):239-248. doi: 10.1007/s00408-017-0076-4. Epub 2017 Dec 11.
6
Course and prognosis of sarcoidosis in a referral setting in Turkey; analysis of 166 patients.土耳其转诊机构中结节病的病程及预后;166例患者分析
Acta Medica (Hradec Kralove). 2006;49(1):51-7.
7
Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.韩国的结节病流行率和发病率:一项全国性基于人群的研究。
Respir Res. 2018 Aug 28;19(1):158. doi: 10.1186/s12931-018-0871-3.
8
[Prognosis and prognostic factors of sarcoidosis in Japan].[日本结节病的预后及预后因素]
Nihon Rinsho. 2002 Sep;60(9):1839-44.
9
The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008-2015: a nationwide population-based study.2008 - 2015年韩国结节病的发病率、合并症及死亡率:一项基于全国人口的研究
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(1):24-26. doi: 10.36141/svdld.v37i1.7660. Epub 2020 Mar 15.
10
Analysis of sarcoidosis in the Oporto region (Portugal).葡萄牙波尔图地区结节病的分析。
Rev Port Pneumol (2006). 2017 Sep-Oct;23(5):251-258. doi: 10.1016/j.rppnen.2017.05.004. Epub 2017 Jun 16.

引用本文的文献

1
Nationwide Cross-Sectional Analysis of Mortality Trends in Patients with Sarcoidosis and Non-Ischemic Cardiovascular Disease-The Impact of Gender, Ethnicity, Geographical Location, and COVID-19 Pandemic.结节病和非缺血性心血管疾病患者死亡率趋势的全国性横断面分析——性别、种族、地理位置及新冠疫情的影响
J Clin Med. 2024 Dec 8;13(23):7463. doi: 10.3390/jcm13237463.
2
Concurrent Occurrence of Neuropsychiatric Systemic Lupus Erythematosus and Sarcoidosis: A Case Report.神经精神性系统性红斑狼疮与结节病并发:一例报告
Cureus. 2023 Oct 4;15(10):e46464. doi: 10.7759/cureus.46464. eCollection 2023 Oct.
3
Fatigue in Patients with Sarcoidosis in Denmark.

本文引用的文献

1
The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008-2015: a nationwide population-based study.2008 - 2015年韩国结节病的发病率、合并症及死亡率:一项基于全国人口的研究
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(1):24-26. doi: 10.36141/svdld.v37i1.7660. Epub 2020 Mar 15.
2
Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts.结节病的临床特征和器官系统受累:明尼苏达大学队列与其他队列的比较。
BMC Pulm Med. 2020 Jun 1;20(1):155. doi: 10.1186/s12890-020-01191-x.
3
Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.
丹麦结节病患者的疲劳情况。
Lung. 2023 Feb;201(1):103-110. doi: 10.1007/s00408-023-00602-0. Epub 2023 Feb 11.
4
HLA class II variants defined by next generation sequencing are associated with sarcoidosis in Korean patients.下一代测序定义的 HLA Ⅱ类变体与韩国患者的结节病有关。
Sci Rep. 2022 Jun 3;12(1):9302. doi: 10.1038/s41598-022-13199-w.
肺结节病的转归:一项基于人群的1976 - 2013年研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(2):123-128. doi: 10.36141/svdld.v35i2.6356. Epub 2018 Apr 28.
4
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
5
Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.韩国的结节病流行率和发病率:一项全国性基于人群的研究。
Respir Res. 2018 Aug 28;19(1):158. doi: 10.1186/s12931-018-0871-3.
6
Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan.日本全国范围内的器官特异性患病率及其与结节病相互关系的调查。
Sci Rep. 2018 Jun 21;8(1):9440. doi: 10.1038/s41598-018-27554-3.
7
Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: A nationwide population-based study.2003-2015 年韩国结节病的患病率、发病率和死亡率:一项基于全国人口的研究。
Respir Med. 2018 Nov;144S:S28-S34. doi: 10.1016/j.rmed.2018.03.028. Epub 2018 Apr 3.
8
Sarcoidosis mortality in Sweden: a population-based cohort study.瑞典的肉样瘤病死亡率:一项基于人群的队列研究。
Eur Respir J. 2018 Feb 21;51(2). doi: 10.1183/13993003.01815-2017. Print 2018 Feb.
9
Phenotypes of organ involvement in sarcoidosis.结节病器官受累的表型。
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.00991-2017. Print 2018 Jan.
10
Disease Burden and Variability in Sarcoidosis.结节病的疾病负担和变异性。
Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S421-S428. doi: 10.1513/AnnalsATS.201707-564OT.